ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

ATHE Alterity Therapeutics Limited

1,8501
-0,0049 (-0,26%)
07 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Alterity Therapeutics Limited ATHE NASDAQ Recibo de Depósito
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,0049 -0,26% 1,8501 18:52:33
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,85 1,85 1,9099 1,8501 1,855
mais cotações »

Notícias Recentes

Data Hora Fonte Título
29/05/202420:21GLOBEAlterity Therapeutics to Host Webcast Today on New Data from..
08/05/202408:25GLOBEAlterity Therapeutics Phase 2 Data Monitoring Committee..
30/04/202408:25GLOBEAppendix 4C – Q3 FY24 Quarterly Cash Flow Report
29/04/202408:25GLOBEAlterity Therapeutics Presents New Data Demonstrating..
17/04/202408:25GLOBEAlterity Therapeutics Parkinson’s Disease and Multiple..
10/04/202408:25GLOBEAlterity Therapeutics to Present New Data on ATH434 at the..
26/03/202411:25GLOBEAlterity Therapeutics Receives a A$3.9 Million Research &..
20/02/202412:25GLOBEAlterity Therapeutics to Present New Data at the Upcoming..
06/02/202409:25GLOBEAlterity Therapeutics Phase 2 Data Monitoring Committee..
29/01/202409:24GLOBEAlterity Therapeutics to Participate in the ShareCafe Hidden..
22/01/202409:25GLOBEAlterity Therapeutics Issues Shareholder Letter Highlighting..
21/12/202302:30GLOBEAlterity Therapeutics Appoints Phillip Hains as Chief..
04/12/202318:35GLOBEAlterity Therapeutics to Host Webcast to Discuss ATH434..
04/12/202309:25GLOBEAlterity Therapeutics Reports Positive Efficacy Data for..
27/11/202309:25GLOBEAlterity Therapeutics Announces Presentation of Novel..
16/11/202309:25GLOBEAlterity Therapeutics Announces Presentation of New Data..
08/11/202309:25GLOBEAlterity Therapeutics Completes Enrolment in ATH434-201..
30/10/202308:25GLOBEAppendix 4C – Q1 FY24 Quarterly Cash Flow Report
31/08/202308:25GLOBEAlterity Therapeutics Presents New Data on Multiple System..
23/08/202308:25GLOBEAlterity Therapeutics Granted New Composition of Matter..
22/08/202308:25GLOBEAlterity Therapeutics Rare Disease Natural History Study to..
15/08/202308:25GLOBEAlterity Therapeutics Receives a $4.74 million Research &..
31/07/202308:52GLOBEAppendix 4C – Q4 FY23 Quarterly Cash Flow Report
26/07/202308:25GLOBEAlterity Therapeutics Phase 2 Data Monitoring Committee..
21/06/202308:25GLOBEAlterity Therapeutics to Present in MST Access Rare..

Seu Histórico Recente

Delayed Upgrade Clock